Description Usage Arguments Details Value References Examples
crm
is used to compute a dose for the next patient in a phase I
trial according to the CRM.
1 2 3 4 |
prior |
A vector of initial guesses of toxicity probabilities associated the doses. |
target |
The target DLT rate. |
tox |
A vector of patient outcomes; 1 indicates a toxicity, 0 otherwise. |
level |
A vector of dose levels assigned to patients. The length
of |
n |
The number of patients enrolled. |
dosename |
A vector containing the names of the regimens/doses
used. The length of |
include |
A subset of patients included in the dose calculation. |
pid |
Patient ID provided in the study. Its length must be equal
to that of |
conf.level |
Confidence level for the probability/confidence interval of the returned dose-toxicity curve. |
method |
A character string to specify the method for parameter
estimation. The default method |
model |
A character string to specify the working model used in
the method. The default model is |
intcpt |
The intercept of the working logistic model. The
default is 3. If |
scale |
Standard deviation of the normal prior of the model parameter. Default is sqrt(1.34). |
model.detail |
If FALSE, the model content of an |
patient.detail |
If FALSE, patient summary of an |
var.est |
If TRUE, variance of the estimate of the model parameter and probability/confidence interval for the dose-toxicity curve will be computed |
For maximum likelihood estimation, the variance of the estimate of
β (post.var
) is approximated by the posterior variance of
β with a dispersed normal prior.
The empiric model is specified as F(d, β) = d^{\exp(β)}.
The logistic model is specified as logit (F(d,β)) = intcpt
+ \exp(β) \times d. For method="bayes"
, the prior on
β is normal with mean 0. Exponentiation of β ensures an
increasing dose-toxicity function.
An object of class "mtd"
is returned, consisting of the summary
of dose assignments thus far and the recommendation of dose for the
next patient.
prior |
Initial guesses of toxicity rates. |
target |
The target probability of toxicity at the MTD. |
ptox |
Updated estimates of toxicity rates. |
ptoxL |
Lower confidence/probability limits of toxicity rates. |
ptoxU |
Upper confidence/probability limits of toxicity rates. |
mtd |
The updated estimate of the MTD. |
prior.var |
The variance of the normal prior. |
post.var |
The posterior variance of the model parameter. |
estimate |
Estimate of the model parameter. |
method |
The method of estimation. |
model |
The working model. |
dosescaled |
The scaled doses obtained via backward substitution. |
tox |
Patients' toxicity indications. |
level |
Dose levels assigned to patients. |
O'Quigley, J. O., Pepe, M., and Fisher, L. (1990). Continual reassessment method: A practical design for phase I clinical trials in cancer. Biometrics 46:33-48.
Cheung, Y. K. (2011). Dose Finding by the Continual Reassessment Method. New York: Chapman & Hall/CRC Press.
1 2 3 4 5 6 7 |
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.